India, March 18 -- Cardiac troponins are a group of markers used to predict the risk of heart disease. However, it is not well understood how controlling blood pressure affects levels of troponin I and whether the change in troponin I levels predicted the future risk of cardiovascular disease. Physician-scientists at the University of Alabama at Birmingham Marnix E. Heersink School of Medicine leveraged data from the Systolic Blood Pressure Intervention Trial, a large nationwide clinical trial, to shed new light on the role of cardiac troponin I in managing blood pressure and predicting cardiovascular disease risk in their recent manuscript published in JACC: Advances.

Hypertension affects nearly half the United States population. Indivi...